Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Radiopharm Theranostics (NASDAQ:RADX) through any online brokerage.
Other companies in Radiopharm Theranostics’s space includes: Serina Therapeutics Inc (AMEX:SER), Skye Bioscience Inc (NASDAQ:SKYE), Intensity Therapeutics Inc (NASDAQ:INTS), FibroGen Inc (NASDAQ:FGEN) and Barinthus Biotherapeutics PLC (NASDAQ:BRNS).
Radiopharm Theranostics has a consensus price target of $14.33.
The stock price for Radiopharm Theranostics (NASDAQ: RADX) is $11.16 last updated December 15, 2025 at 3:09 PM EST.
There are no upcoming dividends for Radiopharm Theranostics.
Radiopharm Theranostics does not have any upcoming earnings scheduled.
There is no upcoming split for Radiopharm Theranostics.
Radiopharm Theranostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.